# Comparison of the Alpha-2 Agonists for Prevention of Intraocular Pressure Elevation After Selective Laser Trabeculoplasty

> **NCT00567411** · NA · UNKNOWN · sponsor: **Walter Reed Army Medical Center** · enrollment: 43 (estimated)

## Conditions studied

- Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** brimonidine 0.1%
- **DRUG:** Apraclonidine 0.5%

## Key facts

- **NCT ID:** NCT00567411
- **Lead sponsor:** Walter Reed Army Medical Center
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-08
- **Primary completion:** —
- **Final completion:** 2009-06
- **Target enrollment:** 43 (ESTIMATED)
- **Last updated:** 2007-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00567411

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00567411, "Comparison of the Alpha-2 Agonists for Prevention of Intraocular Pressure Elevation After Selective Laser Trabeculoplasty". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00567411. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*